Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France

被引:0
|
作者
Oluwaseun, Sharomi [1 ]
Cagnan, Lauren [2 ]
Xausa, Ilaria [3 ]
Nachbar, Robert B. [3 ]
Bachelot, Laurie Levy [4 ]
Chen, Yao-Hsuan [5 ]
Carias, Cristina [6 ]
机构
[1] Merck & Co Inc, BARDS HEDS Dept, Rahway, NJ USA
[2] MSD France, Market Access Dept, Courbevoie, France
[3] Wolfram Res Inc, Wolfram Solut Dept, Champaign, IL USA
[4] MSD France, CORE Reg, Courbevoie, France
[5] MSD UK Ltd, BARDS HEDS, London, England
[6] Merck & Co Inc, CORE PL, Rahway, NJ USA
关键词
rotavirus vaccines; vaccination; France; COST-EFFECTIVENESS; GASTROENTERITIS; CHILDREN; BURDEN; HOSPITALIZATIONS; INFECTIONS; PROTECTION; MORBIDITY; EFFICACY; DISEASES;
D O I
10.1097/INF.0000000000004448
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective:In June 2022, French health authorities issued a universal recommendation for routine administration and reimbursement of rotavirus vaccines in infants. Given this recent recommendation by French health authorities, we sought to understand the public health impact of a universal rotavirus vaccination strategy compared with no vaccination.Materials and Methods:A deterministic, age-structured, nonlinear dynamic transmission model, accounting for herd immunity, was developed. We considered 3 vaccination coverage scenarios: high (95%), medium (75%) and low (55%). Model parameter values were based on published modeling and epidemiological literature. Model outcomes included rotavirus gastroenteritis (RVGE) cases and healthcare resource utilization due to RVGE (hospitalizations, general practitioner or emergency department visits), as well as the number needed to vaccinate to prevent 1 RVGE case (mild or severe) and 1 RVGE-related hospitalization. Model calibration and analyses were conducted using Mathematica 11.3.Results:Over 5 years following implementation, RVGE cases for children under 5 years are estimated to be reduced by 84% under a high vaccination coverage scenario, by 72% under a medium vaccination coverage scenario and by 47% under a low vaccination coverage scenario. Across all scenarios, the number needed to vaccinate to avert 1 RVGE case and hospitalization varied between 1.86-2.04 and 24.15-27.44, respectively.Conclusions:Rotavirus vaccination with high vaccination coverage in France is expected to substantially reduce the number of RVGE cases and associated healthcare resource utilization.
引用
收藏
页码:902 / 908
页数:7
相关论文
共 50 条
  • [1] Modeling the Public Health Impact of a Universal Rotavirus Program in the Netherlands
    Dolk, C.
    Sharomi, O.
    Carias, C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S192 - S193
  • [2] Budget impact of a universal rotavirus vaccination programme with RotaTeq® in France
    Trichard, M.
    Largeron, N.
    Soum, S.
    Saint-Sardos, C.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A352 - A352
  • [3] Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008
    Esposito, Douglas H.
    Tate, Jacqueline E.
    Kang, Gagandeep
    Parashar, Umesh D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : 171 - 177
  • [4] COMPARATIVE PUBLIC HEALTH IMPACT OF ROTAVIRUS VACCINATION IN CHINA
    Oluwaseun, S.
    Yang, C.
    Tu, S. J. Si
    Song, Y.
    Han, F.
    Gu, C.
    Signorovitch, J.
    Wang, X. C.
    Bian, R.
    Carias, C.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S131 - S132
  • [5] Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage
    Costantino, Claudio
    Restivo, Vincenzo
    Tramuto, Fabio
    Casuccio, Alessandra
    Vitale, Francesco
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) : 2297 - 2302
  • [6] Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda
    Tate, Jacqueline E.
    Kisakye, Annet
    Mugyenyi, Prosper
    Kizza, Diana
    Odiit, Amos
    Braka, Fiona
    [J]. VACCINE, 2011, 29 (17) : 3329 - 3334
  • [7] Health impact of rotavirus vaccination in China
    Oluwaseun, Sharomi
    Yang, Chelsey
    Tu, Su Jian Si
    Yin, Jia
    Song, Yan
    Sun, Qiang
    Kanibir, Nabi
    Hartwig, Susanne
    Carias, Cristina
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [8] Economic impact of a rotavirus vaccination program in Mexico
    Constenla, Dagna
    Velazquez, F. Raul
    Rheingans, Richard D.
    Antil, Lynn
    Cervantes, Yolanda
    [J]. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 25 (06): : 481 - 490
  • [9] Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq® in France
    Huet, Frederic
    Largeron, Nathalie
    Trichard, Melanie
    Miadi-Fargier, Houda
    Jasso-Mosqueda, Guillermo
    [J]. VACCINE, 2007, 25 (34) : 6348 - 6358
  • [10] Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly, Deborah E.
    Lewis, Kristen D. C.
    Tate, Jacqueline
    Parashar, Umesh D.
    Rheingans, Richard D.
    [J]. VACCINE, 2012, 30 : A7 - A14